Aveanna Healthcare Holdings Stock Revenue Per Share

AVAH Stock  USD 5.85  0.04  0.69%   
Aveanna Healthcare Holdings fundamentals help investors to digest information that contributes to Aveanna Healthcare's financial success or failures. It also enables traders to predict the movement of Aveanna Stock. The fundamental analysis module provides a way to measure Aveanna Healthcare's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Aveanna Healthcare stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Aveanna Healthcare Holdings Company Revenue Per Share Analysis

Aveanna Healthcare's Revenue per Share is a ratio of total revenue earned per one share of common stock over a single fiscal year. It is calculated by dividing sales revenue earned over 12 months by the average number of outstanding shares. Revenue used in the calculation of this ratio is typically recorded when cash or cash equivalents are exchanged for services or goods.

Revenue Per Share

 = 

Total Sales

Average Shares

More About Revenue Per Share | All Equity Analysis
Revenue per share does not take into account any of company expenses and is helpful only when comparing relative sale figures within a given industry.
Competition

Based on the latest financial disclosure, Aveanna Healthcare Holdings has a Revenue Per Share of 0.0 times. This indicator is about the same for the Health Care Equipment & Supplies average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).

Aveanna Revenue Per Share Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Aveanna Healthcare's direct or indirect competition against its Revenue Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Aveanna Healthcare could also be used in its relative valuation, which is a method of valuing Aveanna Healthcare by comparing valuation metrics of similar companies.
Aveanna Healthcare is currently under evaluation in revenue per share category among its peers.

Aveanna Fundamentals

About Aveanna Healthcare Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Aveanna Healthcare Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aveanna Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aveanna Healthcare Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

When determining whether Aveanna Healthcare offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Aveanna Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Aveanna Healthcare Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Aveanna Healthcare Holdings Stock:
Check out Aveanna Healthcare Piotroski F Score and Aveanna Healthcare Altman Z Score analysis.
You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aveanna Healthcare. If investors know Aveanna will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aveanna Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Aveanna Healthcare is measured differently than its book value, which is the value of Aveanna that is recorded on the company's balance sheet. Investors also form their own opinion of Aveanna Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Aveanna Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aveanna Healthcare's market value can be influenced by many factors that don't directly affect Aveanna Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aveanna Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aveanna Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aveanna Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.